Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült Államok2/3. fázis

A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis

A legfontosabb adatok

Hol
Ann Arbor, Atlanta, Baltimore, Birmingham, Boston, Brooklyn, Chapel Hill, Charleston, Chicago, Cleveland, Durham, Fairborn, Greenville, Hershey, Houston, Kansas City, Lake Success, Lebanon, Louisville, Madison, Milwaukee, New Haven, New Orleans, New York, Norfolk, Philadelphia, Phoenix, Richmond, Rochester, San Francisco, Sandy Springs, St Louis, Troy, Tucson és Washington D.C. (Egyesült Államok)Mind a 35 helyszín megnézése
Fázis
2/3. fázis

Helyszínek itt: Egyesült Államok

  • Ann Arbor, MichiganHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Atlanta, GeorgiaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Baltimore, MarylandHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Birmingham, AlabamaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Boston, MassachusettsHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Brooklyn, New YorkHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Chapel Hill, North CarolinaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Charleston, South CarolinaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Chicago, IllinoisHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Cleveland, OhioHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Durham, North CarolinaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Fairborn, OhioHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Greenville, South CarolinaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Hershey, PennsylvaniaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Houston, TexasHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Kansas City, MissouriHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Lake Success, New YorkHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Lebanon, New HampshireHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Louisville, KentuckyHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Madison, WisconsinHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Milwaukee, WisconsinHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • New Haven, ConnecticutHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • New Orleans, LouisianaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • New YorkHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Norfolk, VirginiaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Philadelphia, PennsylvaniaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Phoenix, ArizonaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Richmond, VirginiaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Rochester, MinnesotaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • San Francisco, CaliforniaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Sandy Springs, GeorgiaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • St Louis, MissouriHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Troy, MichiganHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Tucson, ArizonaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres
  • Washington D.C., District of ColumbiaHospital not named in the registryContact: Clinical Trial AdministratorRésztvevőt keres

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Priovant Therapeutics, Inc.
Azonosító
NCT06978725EU 2026-526437-25-00
A regiszteradat frissítve
2026. november 3.
Eredeti leírás
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.A teljes eredeti leírásKevesebb

A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Cutaneous Sarcoidosis

This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.

Bevonási feltételek: Adults subjects; Cutaneous sarcoidosis with characteristic skin biopsy histology; A CSAMI activity score ≥ 10; Weight > 40 kg to < 130 kg, and with a body mass index (BMI) ≤ 45 kg/m2.

Kizáró feltételek: History of cancer, with the exception of the following cancers with documentation of complete resection and no evidence of recurrence for ≥ 1 year: basal cell carcinoma, squamous cell carcinoma, or carcinoma in situ of the uterine cervix; High risk of thrombosis or cardiovascular disease; Active or recent infection; High risk of herpes zoster.

ClinicalTrials.gov NCT06978725 · EU CTIS 2026-526437-25-00